BIO-RAD LABORATORIES-A (BIO)
US0905722072 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 433.28M | 403.81M | 434.00M | 471.00M | 662.00M | |||
| Marketable Securities | 1.21B | 1.20B | 1.36B | 399.00M | 329.00M | |||
| Receivables | 444.81M | 489.02M | 495.00M | 424.00M | 419.00M | |||
| Inventories | 783.37M | 780.52M | 719.00M | 572.00M | 622.00M | |||
| Other Current Assets | 187.08M | 171.65M | 153.00M | 125.00M | 107.00M | |||
| Total Current Assets | 3.06B | 3.05B | 3.16B | 1.99B | 2.14B | |||
| Non-Current Assets | ||||||||
| PPE Net | 711.28M | 723.74M | 680.00M | 716.00M | 694.00M | |||
| Investments And Advances | 8.02B | 7.70B | 8.83B | 14.39B | 9.56B | |||
| Goodwill | 412.82M | 413.57M | 406.00M | 347.00M | 292.00M | |||
| Intangibles | 313.60M | 320.51M | 332.00M | 254.00M | 199.00M | |||
| Other Non-Current Assets | 92.87M | 94.85M | 95.00M | 104.00M | 87.00M | |||
| Total Non-Current Assets | 9.55B | 9.25B | 10.34B | 15.81B | 10.83B | |||
| TOTAL ASSETS | 12.61B | 12.30B | 13.50B | 17.80B | 12.97B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 487.00K | 486.00K | 0.00 | 0.00 | 2.00M | |||
| Accrued Expenses | 186.53M | 180.31M | 231.00M | 313.00M | 259.00M | |||
| Accounts Payable | 102.75M | 429.18M | 135.00M | 142.00M | 139.00M | |||
| Other Current Liabilities | 176.39M | 197.38M | 202.00M | 225.00M | 231.00M | |||
| Total Current Liabilities | 466.15M | 522.80M | 569.00M | 681.00M | 632.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.20B | 1.20B | 1.20B | 11.00M | 12.00M | |||
| Deferred Taxes/Income | 1.54B | 1.48B | 1.77B | 3.06B | 2.08B | |||
| Other Non-Current Liabilities | 352.23M | 360.59M | 350.00M | 358.00M | 372.00M | |||
| Total Non-Current Liabilities | 3.09B | 3.04B | 3.32B | 3.43B | 2.46B | |||
| TOTAL LIABILITIES | 3.56B | 3.56B | 3.89B | 4.11B | 3.09B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 9.64B | 9.26B | 9.90B | 13.53B | 9.27B | |||
| Additional Paid In Capital | 462.63M | 449.07M | 447.00M | 442.00M | 429.00M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 3.00K | 3.00K | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -630.07M | -632.54M | -264.00M | -106.00M | -100.00M | |||
| Other Shareholders' Equity | -427.27M | -336.94M | -457.00M | -181.00M | 273.00M | |||
| Shares Outstanding | 28.52M | 28.52M | 30.00M | 30.00M | 30.00M | |||
| Tangible Book Value per Share | 291.85 | 280.77 | 295.90 | 436.13 | 312.97 | |||
| Total Shareholders' Equity | 9.05B | 8.74B | 9.62B | 13.69B | 9.88B | |||
| TOTAL LIABILITIES AND EQUITY | 12.61B | 12.30B | 13.50B | 17.80B | 12.97B | |||
| Statistics | ||||||||
| Debt/Equity | 0.13 | 0.14 | 0.12 | 0.00 | 0.00 | |||
| Current Ratio | 6.57 | 5.83 | 5.55 | 2.92 | 3.39 | |||
| Return On Assets (ROA) | -2.56% | -5.18% | -26.87% | 23.90% | 29.40% | |||
| Return On Equity (ROE) | -3.56% | -7.29% | -37.73% | 31.09% | 38.61% | |||
| Return On Invested Capital (ROIC) | 2.25% | 2.45% | 2.97% | 2.61% | 2.70% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 2.60% | 2.84% | 3.45% | 2.75% | 2.93% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 2.79% | 3.06% | 3.70% | 2.85% | 3.06% | |||
All data in USD